Tirzepatide 30mg

Description

Tirzepatide Overview

Tirzepatide is a dual GIP and GLP-1 receptor agonist that has become one of the most extensively studied incretin-based compounds for blood-glucose control and weight management.

Note: Tirzepatide is sometimes incorrectly marketed as “GLP-1.2.” Its established pharmacology is GIP/GLP-1 receptor agonism.

Product Information

Tirzepatide activates both GIP and GLP-1 receptors. These pathways influence glucose-dependent insulin secretion, appetite signaling, gastric emptying, and energy balance.

Large clinical trials have demonstrated substantial body-weight reduction and improvements in glycemic measures.

How Does Tirzepatide Work?

Tirzepatide activates GIP and GLP-1 receptors, influencing glucose regulation, appetite, and energy balance.

Tirzepatide Benefits & Effects

Promotes Weight Reduction

Clinical trials have demonstrated substantial reductions in body weight with Tirzepatide compared with placebo.

Improves Blood-Glucose Control

Tirzepatide improves glucose-dependent insulin secretion and has demonstrated significant reductions in HbA1c.

Reduces Appetite

GIP and GLP-1 signaling influences satiety and food intake, contributing to reduced appetite.

Supports Metabolic Research

Tirzepatide is extensively studied in obesity, type 2 diabetes, and broader metabolic research.